E-DRUG: Pharmaceutical Compounding and Access to Medicines
--------------------------------------------------
Dear E-druggers
Access to medicines is a major problem especially in developing countries with little manufacturing capacities. Pharmaceutical compounding, which several years ago was almost completely replaced by mass large scale manufacturing of medicines may still be of importance where primary ingredients of good quality can be obtained.
My experience is that pharmaceutical compounding has created opportunities for patients to obtain cheaper effective medicines like podophyllin paint whose commercially available brand is about 10 times the cost of the compounded equivalent. This medicine is used to treat warts, a condition that has become more common with immunocompromised patients. Similarly, discomfort resultng from urinary tract infection is a recurrent problem. Often this discomfort has been treated as resurgence of UTI. However, potassium citrate mixture is the solution. This is a locally compounded product whose branded equivalent cannot be found in Cameroon.
I would like to stimulate the interest of most e-druggers on the importance of compounding as an essential tool to improving access to medicines and thus enhancing the quality of life of patients.
What do you think about this?
Regards
Robert Chana
Pharmacist
Cameroon
robert chana <chana_robert@yahoo.co.uk>